Janoshik Laboratory Verified
Independent third-party testing confirms purity and concentration
21.87mg Actual Content 20mg Label Claim 109% Accuracy Verification Key: FK4PKY9KD13E | Tested: October 2025 | View Full Report
Quanta Pharma SLU-PP-332 20mg is a cutting-edge ERRα/γ (estrogen-related receptor) agonist that has gained significant attention in performance research. Often dubbed “exercise in a pill,” this Quanta Pharma compound is being studied for its remarkable ability to enhance endurance and metabolic function without the need for physical training. Janoshik laboratory testing confirms accurate dosing at 21.87mg per tablet. Dispatched from UK stock for fast delivery.
Quanta Pharma SLU-PP-332 Specifications
Tablets 60 Dose Per Tablet 20mg Half-Life 4-6 Hours Administration Oral Official Quanta Pharma Verified Reseller Pharmaceutical-grade compounds • UK stock • Fast dispatch
Quanta Pharma SLU-PP-332 Research Benefits
- Enhanced Endurance – Research shows significant improvements in exercise capacity and stamina
- Metabolic Activation – Activates ERR receptors involved in energy metabolism and mitochondrial function
- Fat Oxidation – Promotes the body’s ability to utilise fat as fuel during activity
- Muscle Fibre Adaptation – Studies indicate shifts towards oxidative (slow-twitch) muscle characteristics
- No Training Required – Research demonstrates benefits even in sedentary models
How Quanta Pharma SLU-PP-332 Works
Quanta Pharma SLU-PP-332 works by activating estrogen-related receptors alpha and gamma (ERRα/γ), which are key regulators of energy metabolism, mitochondrial biogenesis, and oxidative phosphorylation. These receptors control genes involved in fatty acid oxidation, glucose metabolism, and the formation of new mitochondria.
Research published in leading scientific journals has demonstrated that Quanta Pharma SLU-PP-332 can mimic many of the beneficial adaptations normally associated with endurance exercise training. Studies in animal models showed dramatic improvements in running endurance, increased oxidative muscle fibres, and enhanced metabolic markers without any physical training stimulus.
Quanta Pharma SLU-PP-332 vs GW501516 (Cardarine)
Both Quanta Pharma SLU-PP-332 and GW501516 are researched for endurance enhancement, but they work through different mechanisms. GW501516 is a PPARδ agonist, whilst SLU-PP-332 targets ERR receptors. Quanta Pharma SLU-PP-332 is a newer compound with a potentially improved safety profile based on its mechanism of action. Many researchers are now favouring Quanta Pharma SLU-PP-332 as an alternative approach to metabolic and endurance research.
Why Choose Quanta Pharma SLU-PP-332?
Quanta Pharma is renowned for producing pharmaceutical-grade compounds with exceptional quality and accurate dosing. Every batch of Quanta Pharma SLU-PP-332 undergoes rigorous quality control and Janoshik laboratory verification. With confirmed content of 21.87mg per tablet (slightly overdosed), you can trust that each bottle delivers precisely what’s promised.
⚠️ FOR RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Legal Notice: This product is intended for research purposes only. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations. Not for use in dietary supplements, food products, or for any unlawful purpose.
Related products
